ACOR

Acorda Therapeutics, Inc. Press Releases

$31.31
*  
0.30
0.97%
Get ACOR Alerts
*Delayed - data as of Jul. 10, 2014  -  Find a broker to begin trading ACOR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ACOR After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Actavis Confirms Generic Ampyra® Patent Challenge
7/8/2014 4:05:00 PM - PR Newswire

Acorda Therapeutics Announces Notification of ANDA Filing for AMPYRA®
6/26/2014 6:00:00 AM - Business Wire

Acorda Therapeutics Announces Pricing of $300 Million of 1.75% Convertible Senior Notes Due 2021
6/18/2014 6:00:00 AM - Business Wire

Acorda Therapeutics Announces Public Offering of Convertible Senior Notes Due 2021
6/16/2014 4:11:00 PM - Business Wire

Scanning Biotech Equities -- Research on ACADIA Pharma, Acorda Therapeutics, Alnylam Pharma, and BioCryst Pharma
6/13/2014 8:20:00 AM - PR Newswire

Data from Biogen Idec’s Portfolio of Multiple Sclerosis Therapies and Pipeline Featured at Medical Congresses
5/30/2014 7:30:00 AM - Business Wire

Acorda Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference
5/28/2014 7:00:00 AM - Business Wire

Acorda Therapeutics to Showcase Online Multiple Sclerosis Resources at 2014 CMSC/ACTRIMS Meeting
5/27/2014 7:02:00 AM - Business Wire

Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
5/14/2014 7:02:00 AM - Business Wire

Acorda Therapeutics to Present at the UBS Global Healthcare Conference
5/13/2014 7:00:00 AM - Business Wire

Technical Updates on Biotech Stocks -- Research on Alexion Pharma, Acorda Therapeutics, Clovis Oncology, and Sangamo BioSciences
5/9/2014 12:30:00 PM - PR Newswire

Acorda Therapeutics Named One of the Best Places to Work for in New York 2014
5/7/2014 7:02:00 AM - Business Wire

Acorda Therapeutics Reports First Quarter 2014 Financial Results
5/6/2014 6:00:00 AM - Business Wire

Acorda Therapeutics to Present at the Deutsche Bank’s 39th Health Care Conference
4/30/2014 7:00:00 AM - Business Wire

Acorda Therapeutics to Host Conference Call to Discuss First Quarter 2014 Financial Results on May 6, 2014
4/29/2014 7:00:00 AM - Business Wire

Biogen Idec to Present New Clinical Data from Its Robust Neurology Portfolio at AAN Annual Meeting
4/14/2014 7:30:00 AM - Business Wire